BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Viventia Biotech Inc. Reports On Progress Of Anti-Cancer Pipeline At PEGS Korea 2015

  September 8, 2015

   · 

  3 min read
• Biotech Bay

  Versartis, Inc. Announces Agenda And Event Details For Investor Symposium Featuring Global Opinion Leaders In Pediatric Human Growth Hormone Deficiency (GHD)

  September 8, 2015

   · 

  5 min read
• Drug Development

  Valeant And Progenics Pharmaceuticals, Inc. Announce FDA Acceptance Of NDA Submission For Oral RELISTOR

  September 8, 2015

   · 

  5 min read
• Business

  Oxis Biotech Licenses Exclusive Worldwide Rights To Novel Cancer Therapy

  September 8, 2015

   · 

  6 min read
• Pharm Country

  Mylan Launches Generic Yasmin Tablets

  September 8, 2015

   · 

  2 min read
• Drug Development

  Rigel Granted Orphan Drug Designation For Fostamatinib In ITP

  September 8, 2015

   · 

  4 min read
• Drug Development

  U.S. FDA Grants Priority Review To Janssen Research & Development For Daratumumab As A Treatment For Multiple Myeloma

  September 8, 2015

   · 

  8 min read
• Business

  Helsinn Group Signs Exclusive Agreement With Bial For Distribution And Licence Of Anamorelin In Spain, Portugal, Angola And Mozambique

  September 8, 2015

   · 

  6 min read
• Pharm Country

  Vernalis Therapeutics Launches Long-Acting Codeine-Based Cough Suppressant Ahead Of U.S. Cough Cold Season

  September 8, 2015

   · 

  9 min read
• Business

  Neurimmune Therapeutics Receives Major Development Milestone Upon Initiation Of Global Phase 3 Studies With Aducanumab For Early Alzheimer’s Disease

  September 8, 2015

   · 

  3 min read